Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thalidomide therapy. An open trial.

B Naafs, W R Faber

    International Journal of Dermatology
    |March 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Thalidomide is effective for various skin conditions but can cause peripheral neuropathy, limiting its use. This side effect mirrors concerns from its historical teratogenic effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Comments to the letter to the editor by Dr Sweta Subhadarshani.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2019
    Same author

    Position statement: LEPROSY: Diagnosis, treatment and follow-up.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2019
    Same author

    Borderline lepromatous leprosy, Erythema Nodosum Leprosum and a generalized varicella zoster virus infection: a deadly combination.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2017
    Same author

    The clinical spectrum of mycosis fungoides in Tanzania, East Africa.

    The British journal of dermatology·2016
    Same author

    Point-of-care management of urogenital Chlamydia trachomatis via Gram-stained smear analysis in male high-risk patients. Diagnostic accuracy and cost-effectiveness before and after changing the screening indication at the STI Clinic in Amsterdam.

    Sexually transmitted infections·2015
    Same author

    Comparison of two Gram stain point-of-care systems for urogenital gonorrhoea among high-risk patients: diagnostic accuracy and cost-effectiveness before and after changing the screening algorithm at an STI clinic in Amsterdam.

    Sexually transmitted infections·2014
    Same journal

    Preliminary Validation of the Early Sacroiliitis Screening Tool (ESHST) for Identifying Hidradenitis Suppurativa Patients at High Risk of Spondyloarthritis.

    International journal of dermatology·2026
    Same journal

    Increased Risk of Deep Vein Thrombosis and Pulmonary Embolism in Hidradenitis Suppurativa Patients With Down Syndrome: A Retrospective Cohort Study.

    International journal of dermatology·2026
    Same journal

    Efficacy of Intralesional Bevacizumab Versus Intralesional Triamcinolone Acetonide Injection in the Treatment of Keloids: A Randomized Clinical Trial.

    International journal of dermatology·2026
    Same journal

    Application Site Adverse Events of Topical Nonsteroidal Immunomodulators: A Post-Marketing Analysis of the FDA Adverse Event Reporting System.

    International journal of dermatology·2026
    Same journal

    Follicular Disorders Associated With Pseudofolliculitis Barbae: A TriNetX Retrospective Cohort Study.

    International journal of dermatology·2026
    Same journal

    mTOR-Responsive PIK3CA p.E542K-Harboring Sweat Gland Carcinoma With Neuroendocrine Differentiation.

    International journal of dermatology·2026
    See all related articles

    Area of Science:

    • Dermatology
    • Pharmacology
    • Neurology

    Background:

    • Thalidomide has a complex history due to severe side effects.
    • Its therapeutic potential for dermatologic conditions remains an area of interest.

    Purpose of the Study:

    • To evaluate the efficacy of thalidomide in treating a range of dermatologic conditions.
    • To assess the safety profile of thalidomide in this patient cohort.

    Main Methods:

    • An open-label trial was conducted.
    • Thirty-five patients with diverse dermatologic conditions received thalidomide treatment.

    Main Results:

    • Thalidomide demonstrated significant therapeutic value across various dermatologic conditions.
    • Peripheral neuropathy was identified as a notable adverse event.

    Related Experiment Videos

    Conclusions:

    • Thalidomide is a valuable therapeutic option for dermatologic disorders.
    • The risk of peripheral neuropathy may restrict thalidomide's clinical application, similar to its known teratogenic risks.